Articlenpj drug discovery2026
Structure-based TCR-pMHC binding prediction and generalization to unseen peptides.
Article in npj drug discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural quality-tier assessment for TCR-pMHC functional enrichment.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The interaction between T-cell receptors (TCRs) with the peptide-bound major histocompatibility complex (MHC) intricately impacts the functional specificity of T-cell-mediated adaptive immune response. Consequently, implication in immunotherapy has contributed to the ever-growing computational methods for TCR recognition, which have recently attracted structure-based approaches due to advancements in protein structure modeling. Despite access to structural information of the predicted binding interface, graph neural network (GNN)-based TCR-pMHC binding specificity classifiers tend to show poor accuracy for samples with unseen peptides. In this work, we comprehensively assess the potential factors that critically impact the generalization performance of classifiers trained with computationally predicted structures. Specifically, our experiments focus on analyzing the sensitivity of such predictors to the interaction features in the TCR-pMHC interface and the structural uncertainty. Building on the analysis, we demonstrate how the design of classifier architecture with auxiliary training objectives can improve the generalization performance to novel peptides not yet seen during model training. Overall, our work highlights the challenges of unseen peptide generalization from different perspectives of the GNN-based classifier paradigm, showcasing the strengths and weaknesses of the current state-of-the-art approaches in the generalization landscape.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.